National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group (BCB-Sarcomes)

Institut Bergonié

Status: Enrolling

Conditions: Sarcoma

Treatments: Radiation: Radiotherapy; Drug: Immunotherapeutic Agent; Drug: target treatment; Drug: Chemotherapy; Procedure: Surgery

Study type: Observational

Funder types: Other

Identifiers

NCT03978039

IB2012-BCB-SARCOMES

Details and patient eligibility

About

The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas [RESOS] / French expert network dedicated to the pathology of sarcomas [RREPS]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas [NETSARC]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples.

Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes.

With the financial support of the French National Cancer Institute [Institut National du cancer [INCa]).

Enrollment: 150,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria :

• Diagnosis of sarcoma
• Diagnosis in a French Comprehensive Cancer Center
• Any age

Trial design

150,000 participants in 1 patient group

Patients with sarcoma

Description:

Patients with a sarcoma diagnosed in a French Comprehensive cancer Center

Treatment:

Procedure: Surgery

Drug: Chemotherapy

Drug: target treatment

Drug: Immunotherapeutic Agent

Radiation: Radiotherapy